摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Ethyl-3,5-dimethylphenol

中文名称
——
中文别名
——
英文名称
4-Ethyl-3,5-dimethylphenol
英文别名
——
4-Ethyl-3,5-dimethylphenol化学式
CAS
——
化学式
C10H14O
mdl
——
分子量
150.22
InChiKey
UMTDFUPDRXRTGZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

文献信息

  • [EN] BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME<br/>[FR] COMPOSÉS ÉMISSIFS CYCLIQUES CONTENANT DU BORE ET FILM DE CONVERSION DE COULEUR LES CONTENANT
    申请人:NITTO DENKO CORP
    公开号:WO2021146380A1
    公开(公告)日:2021-07-22
    The present disclosure relates to novel photoluminescent complex comprising a BODIPY moiety covalently bonded to a blue light absorbing moiety, and a color conversion film, a back-light unit using the same.
    本公开涉及一种新型的光致发光配合物,该配合物包括一个与蓝色光吸收基团共价键连接的BODIPY部分,以及使用该配合物的色转换膜和背光单元。
  • Phosphate Ester Composition and Use
    申请人:Sasol (USA) Corporation
    公开号:US20180273556A1
    公开(公告)日:2018-09-27
    A phosphate ester composition comprising more than 50 mass % of a phosphate ester represented by Formula 1, wherein X, Y, and Z are independently selected from the group consisting of alkyl, heteroalkyl, heteroaryl or aryl, with at least one of X, Y and Z being aryl, represented by Formula 2, and wherein two or more of R3, R4 and R5 have from 1 to 10 carbon atoms, and the total number of carbon atoms in R3, R4 and R5 is from 3 to 30. The use of the phosphate ester composition as a flame retardant, a lubricant, an anti-wear additive, a hydraulic fluid, a self-extinguishing functional fluid, or an additive thereof.
    一种磷酸酯组合物,其包括质量百分比超过50%的由式子1表示的磷酸酯,其中X、Y和Z独立地选择自烷基、杂烷基、杂芳基或芳基群,其中至少有一个是芳基,由式子2表示,且R3、R4和R5中的两个或更多个具有1至10个碳原子,且R3、R4和R5中的碳原子总数为3至30。将该磷酸酯组合物用作阻燃剂、润滑剂、抗磨添加剂、液压油、自熄功能液体或其添加剂。
  • RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE
    申请人:Conopco, Inc., d/b/a UNILEVER
    公开号:US20160000669A1
    公开(公告)日:2016-01-07
    Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed.
    本文提供了使用间苯二酚衍生物治疗、调节或预防以氧化应激或退化过程为特征的皮肤状况的方法和组合物。还揭示了预防、淡化或减少由皮肤色素沉着、皮肤老化或其他疾病引起的皮肤可见不连续性的方法。
  • Non-Steroidal Ligands for the Glucocorticoid Receptor, Compositions and Uses Thereof
    申请人:Scanlan Thomas S.
    公开号:US20090137655A1
    公开(公告)日:2009-05-28
    The invention provides non-steroidal ligands for the glucocorticoid receptor, methods for making non-steroidal ligands of the glucocorticoid receptor, compositions of non-steroidal ligands of the glucocorticoid receptor and methods of using non-steroidal ligands and compositions of non-steroidal ligands of the glucocorticoid receptor for treating or preventing diseases (e.g., obesity, diabetes, depression, neurodegeneration or an inflammatory disease) associated with glucocorticoid binding to the glucocorticoid receptor.
    本发明提供了糖皮质激素受体的非类固醇配体,制备糖皮质激素受体的非类固醇配体的方法,糖皮质激素受体的非类固醇配体组合物以及使用糖皮质激素受体的非类固醇配体和糖皮质激素受体的非类固醇配体组合物治疗或预防与糖皮质激素结合到糖皮质激素受体相关的疾病(例如肥胖症、糖尿病、抑郁症、神经退行性疾病或炎症性疾病)。
  • TUMOR-INFILTRATING LYMPHOCYTES FOR ADOPTIVE CELL THERAPY
    申请人:H. Lee Moffitt Cancer Center And Research Institute, Inc.
    公开号:EP3698850A1
    公开(公告)日:2020-08-26
    Disclosed are compositions and methods for ex vivo expansion of tumor-infiltrating lymphocytes for use in adoptive cell therapy (ACT). Also disclosed are compositions and method for identifying an agent for ex vivo expansion of tumor-infiltrating lymphocytes for use in ACT. Also disclosed are methods for treating cancer using tumor-infiltrating lymphocytes expanded by the disclosed methods.
    公开了用于收养细胞疗法(ACT)的肿瘤浸润淋巴细胞体外扩增的组合物和方法。还公开了用于体内外扩增肿瘤浸润淋巴细胞的组合物和方法。还公开了使用通过公开方法扩增的肿瘤浸润淋巴细胞治疗癌症的方法。
查看更多